Reid MJA 1
,
Arinaminpathy N 2
,
Bloom A 3
,
Bloom BR 4
,
Boehme C 5
,
Chaisson R 6
Show all authors
,
Chin DP 7
,
Churchyard G 8
,
Cox H 9
,
Ditiu L 10
,
Dybul M 11
,
Farrar J 12
,
Fauci AS 13
,
Fekadu E 14
,
Fujiwara PI 15
,
Hallett TB 2
,
Hanson CL 7
,
Harrington M 16
,
Herbert N 17
,
Hopewell PC 18
,
Ikeda C 19
,
Jamison DT 20
,
Khan AJ 21
,
Koek I 22
,
Krishnan N 23
,
Motsoaledi A 24
,
Pai M 25
,
Raviglione MC 26
,
Sharman A 27
,
Small PM 28
,
Swaminathan S 29
,
Temesgen Z 30
,
Vassall A 31
,
Venkatesan N 32
,
van Weezenbeek K 33
,
Yamey G 34
,
Agins BD 35
,
Alexandru S 36
,
Andrews JR 37
,
Beyeler N 38
,
Bivol S 39
,
Brigden G 15
,
Cattamanchi A 18
,
Cazabon D 40
,
Crudu V 39
,
Daftary A 25
,
Dewan P 41
,
Doepel LK 13
,
Eisinger RW 13
,
Fan V 42
,
Fewer S 38
,
Furin J 43
,
Goldhaber-Fiebert JD 44
,
Gomez GB 45
,
Graham SM 46
,
Gupta D 47
,
Kamene M 48
,
Khaparde S 49
,
Mailu EW 48
,
Masini EO 50
,
McHugh L 51
,
Mitchell E 52
,
Moon S 53
,
Osberg M 54
,
Pande T 40
,
Prince L 44
,
Rade K 55
,
Rao R 56
,
Remme M 57
,
Seddon JA 58
,
Selwyn C 7
,
Shete P 18
,
Sachdeva KS 47
,
Stallworthy G 59
,
Vesga JF 2
,
Vilc V 60
,
Goosby EP 61
Affiliations
- 1 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu
- 2 School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK
- 3 Tuberculosis Division, United States Agency for International Development, Washington, DC, USA
- 4 Department of Global Health and Population, Harvard University, Cambridge, MA, USA
- 5 Foundation for Innovative New Diagnostics, Geneva, Switzerland
- 6 Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA
- 7 Bill & Melinda Gates Foundation, Seattle, WA, USA
- 8 The Aurum Institute, Johannesburg, South Africa
- 9 Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 10 Stop TB Partnership, Geneva, Switzerland
- 11 Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA
- 12 The Wellcome Trust, London, UK
- 13 National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA
- 14 Volunteer Health Services, Addis Ababa, Ethiopia
- 15 Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France
- 16 Treatment Action Group, New York, NY, USA
- 17 Global TB Caucus, Houses of Parliament, London, UK
- 18 Department of Medicine, University of California San Francisco, San Francisco, CA, USA
- 19 Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan
- 20 Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
- 21 Interactive Research & Development, Karachi, Pakistan
- 22 Global Health Bureau, United States Agency for International Development, Washington, DC, USA
- 23 Resource Group for Education and Advocacy for Community Health, Chennai, India
- 24 South African National Department of Health, Pretoria, South Africa
- 25 Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada
- 26 University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland
- 27 Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan
- 28 Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA
- 29 WHO, Geneva, Switzerland
- 30 Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA
- 31 Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands
- 32 The Economic Times, Mumbai, India
- 33 KNCV Tuberculosis Foundation, The Haag, Netherlands
- 34 Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA
- 35 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA
- 36 Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova
- 37 Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
- 38 Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
- 39 Center for Health Policies and Studies, Chisinau, Moldova
- 40 McGill International TB Center, McGill University, Montreal, QC, Canada
- 41 Bill & Melinda Gates Foundation, New Delhi, India
- 42 T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA
- 43 Division of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA
- 44 Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
- 45 Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK
- 46 Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia
- 47 Revised National TB Control Program, New Delhi, India
- 48 National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya
- 49 General TB control, New Delhi, India
- 50 WHO, Nairobi, Kenya
- 51 Office of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland
- 52 International Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland
- 53 Department of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland
- 54 Linksbridge, Seattle, WA, USA
- 55 Central Tuberculosis Division, WHO, New Delhi, India
- 56 Ministry of Health and Family Welfare, New Delhi, India
- 57 International Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia
- 58 Department of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa
- 59 Seattle, WA, USA
- 60 National TB Program, WHO, Chisinau, Moldova
- 61 Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA
Lancet, 2019 Mar 30;393(10178):1331-1384.
PMID: 30904263
DOI: 10.1016/S0140-6736(19)30024-8
* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.